Events

Videos

Podcasts

Articles

Clinical

® Clinical Focus page includes a listing of all specialities covered across  OncLive.com, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, hematologic malignancies, and gynecologic cancers. Each individual specialty page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances in both the localized and metastatic settings, and ongoing research.


The combination of the immunotherapy CRS-207 and the vaccine GVAX Pancreas has received a breakthrough therapy designation from the FDA for its potential as a treatment for patients with metastatic pancreatic cancer.

Immunotherapy Combination Receives Breakthrough Designation for Pancreatic Cancer

Future Immunotherapy Strategies in Cancer

Checkpoint Inhibitors Under Exploration in RCC

Return of Interferon in RCC

Potential Immunotherapy Combinations in RCC

PD-1 Combinations Explored in RCC

Immunotherapy Combination Strategies in RCC

Sequencing Checkpoint Inhibitors in NSCLC

Optimizing Checkpoint Inhibition in NSCLC

Immune Checkpoint Inhibitors in NSCLC

Evolving Renal Cell Carcinoma Treatment Paradigm

Rini Explores PD-1 Inhibition in Renal Cell Carcinoma

Development of Checkpoint Inhibitors for GU Cancers

Checkpoint Inhibition in Renal Cell Carcinoma

Utility of PD-L1 as a Biomarker in Bladder Cancer

Evolving Role of PD-L1 as a Biomarker

PD-L1 Immunotherapy in Bladder Cancer

Targeted Immunotherapy in Cancer

Future Role of Immunotherapy in Cancer

PD-L1 Inhibition With MPDL3280A in Bladder Cancer

Immuno-Oncology

Immuno-Oncology | Specialty